The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

Medtronic plans to use data from the ADAPT-PD trial to support the Percept PC’s aDBS global regulatory filing. Image credit: JHVEPhoto / Shutterstock. Medtronic has published preliminary data from a ...

Patritumab deruxtecan’s safety profile in the trial was in line with previous lung cancer studies. Credit: Jo Panuwat D/Shutterstock. Daiichi Sankyo and MSD (Merck & Co) have reported that the Phase ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

The Phase III NIAGARA study evaluating AstraZeneca‘s Imfinzi (durvalumab) for neoadjuvant and adjuvant cisplatin-eligible muscle-invasive bladder cancer (MIBC) results were presented at European ...

Clinical data management companies support the process of data collection, validation, and preparation for statistical analysis for clinical trials. Efficient clinical trial data management can help ...

The US Food and Drug Administration (FDA) has lifted a clinical hold on Zentalis Pharmaceuticals’ azenosertib. Credit: PeopleImages.com – Yuri A via Shutterstock. The US Food and Drug Administration ...

The comments on the new FDA draft guidance must be submitted by 16 November. Image credit: Tada Images / Shutterstock. The US Food and Drug Administration (FDA) has released a new draft guidance on ...

The trial enrolled 1,324 patients with unresectable hepatocellular carcinoma. Credit: Jo Panuwat D / Shutterstock. UK-based pharmaceutical company AstraZeneca has reported positive results from the ...

Digitalising clinical trials can improve accessibility and engagement for participants, as well as data collection and analytics. It has the potential to lower clinical trial expenses, reduce manual ...